申请人:Forma Therapeutics, Inc.
公开号:EP3636637A1
公开(公告)日:2020-04-15
The present disclosure is directed to inhibitors of FASN. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of FASN. For instance, the disclosure is concerned with compounds and compositions for inhibition of FASN, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of FASN, and methods of synthesis of these compounds.
本公开涉及FASN的抑制剂。这些化合物可用于治疗与FASN抑制相关的疾病或疾病。例如,本公开涉及用于抑制FASN的化合物和组合物,治疗、预防或改善与FASN抑制相关的疾病或疾病的方法,以及这些化合物的合成方法。